Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
678.00    -7.00 (-1.02%)
Bid:
665.00
Ask:
678.00
Spread: 13.00 (1.955%)
Market Cap: £658.48m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Holding(s) in Company

29 Dec 2014 07:00

RNS Number : 7830A
Acal PLC
29 December 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

ACAL PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)

(if different from 3.): iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date on which the threshold is crossed or reached: v

22 DECEMBER 2014

6. Date on which issuer notified:

23 DECEMBER 2014

7. Threshold(s) that is/are crossed or

reached: vi, vii

19%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0000055888

11,982,750

11,982,750

11,969,870

11,969,870

18.9850%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 11,969,870

 18.9850%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

11,800,000 of these shares are held for unit trusts operated by Marlborough Funds Managers Ltd, for whom Hargreave Hale Ltd manages the investment on a discretionary basis. The remaining balance is held on behalf of other discretionary clients.

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

14. Contact name:

 David Clueit

15. Contact telephone number:

 01253 754739

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEALANAAKLFEF
Date   Source Headline
11th Jun 202610:00 amRNSDirector LTIP & DSBP Awards
3rd Jun 20267:00 amRNSPreliminary results
20th May 20267:00 amRNSNotice of Full Year Results
19th May 20267:00 amRNSAcquisition of 3Gmetalworx
7th May 20261:29 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSQ4 and full year trading update
10th Apr 20269:16 amRNSNotification of Major Holdings
27th Feb 20264:42 pmRNSNotification of Major Holdings
12th Feb 20265:18 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSQ3 Trading Update
29th Jan 20268:58 amRNSDirector/PDMR Shareholding
16th Dec 20254:00 pmRNSNotification of Major Holdings
16th Dec 20259:31 amRNSIssue of Equity & Total Voting Rights
11th Dec 20254:02 pmRNSDirector/PDMR Shareholding
4th Dec 20257:00 amRNSAcquisition of Trival
3rd Dec 20252:55 pmRNSNotification of Major Holdings
2nd Dec 20257:00 amRNSInterim Results
19th Nov 20257:15 amRNSDirector Declaration
18th Nov 20259:16 amRNSNotice of Half Year Results
28th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
16th Oct 20253:41 pmRNSNotification of Major Holdings
14th Oct 20257:00 amRNSFirst Half Trading Update
15th Sep 20252:14 pmRNSNotification of Major Holdings
4th Sep 20252:58 pmRNSNotification of Major Holdings
14th Aug 20251:27 pmRNSDirector/PDMR Shareholding
13th Aug 20258:32 amRNSDirector / PDMR Shareholding
4th Aug 20253:44 pmRNSNotification of Major Holdings
24th Jul 20252:37 pmRNSResults of Annual General Meeting
24th Jul 20257:00 amRNSTrading Update
19th Jun 202511:34 amRNSAnnual Report & Notice of AGM
18th Jun 20258:12 amRNSNotification of Major Holdings
16th Jun 20254:30 pmRNSNotification of Major Holdings
12th Jun 202510:20 amRNSDirector LTIP & DSBP Awards
4th Jun 20257:00 amRNSPreliminary results
14th May 20254:13 pmRNSNotification of Major Holdings
14th May 20252:13 pmRNSNotice of Full Year Results
16th Apr 20254:48 pmRNSNotification of Major Holdings
16th Apr 20257:00 amRNSTrading Update
9th Apr 20258:38 amRNSNotification of Major Holdings
26th Mar 20253:08 pmRNSNotification of Major Holdings
12th Mar 20258:39 amRNSDirector/PDMR Shareholdings
5th Mar 20258:05 amRNSDirector Declaration
3rd Mar 20252:20 pmRNSDirector/PDMR Shareholding
26th Feb 20254:56 pmRNSNotification of Major Holdings
18th Feb 20252:52 pmRNSNotification of Major Holdings
17th Feb 20252:37 pmRNSNotification of Major Holdings
14th Feb 20258:28 amRNSDirector / PDMR Shareholding
5th Feb 20251:08 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSQ3 Trading Update
29th Jan 20259:40 amRNSDirector / PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.